Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy.
Human serum albumin (HSA) has its ability to bind drug molecules and influence their efficacies. Although anticancer leads NSC48693 and NSC290956 functioned at the same mechanism, the drug efficacies were obviously distinct. To gain insight into the distinct drug efficacy, the molecular and physiolo...
Main Authors: | Chuanbo Liu, Zuojia Liu, Jin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5398698?pdf=render |
Similar Items
-
Correction: Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy.
by: PLOS ONE Staff
Published: (2017-01-01) -
A biophysical approach of cytarabine anticancer drug insights into human serum albumin and checkpoint kinase 1
by: Manoharan Rupavarshini, et al.
Published: (2023-01-01) -
Insights into the Binding of Dietary Phenolic Compounds to Human Serum Albumin and Food-Drug Interactions
by: Anallely López-Yerena, et al.
Published: (2020-11-01) -
Interactive Association of Drugs Binding to Human Serum Albumin
by: Feng Yang, et al.
Published: (2014-02-01) -
Insights on the in-vitro binding interaction between donepezil and bovine serum albumin
by: Reem N. El Gammal, et al.
Published: (2023-04-01)